Inventor · disambiguated record
Shawn Zinnen
Also filed as: ZINNEN SHAWN · ZINNEN SHAWN P · ZINNEN SHAWN PATRICK
12 granted patents·33 pending applications·787 citations·filing 1999–2022
91Inventor score
Files withSIRNA THERAPEUTICS INC21MBC PHARMA INC7KARPEISKY ALEXANDER2MAXWELL BIOTECH GROUP LTD2RIBOZYME PHARM INC2
Top patents by PatentIndex Score
45 records- 0198US7858769B2RNA interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional siNA)SIRNA THERAPEUTICS INC·Filed 2005·Granted Dec 28, 2010·156 cites·16 claims
- 0296US6617438B1Oligoribonucleotides with enzymatic activitySIRNA THERAPEUTICS INC·Filed 1999·Granted Sep 9, 2003·312 cites·27 claims
- 0396US6528640B1Synthetic ribonucleic acids with RNAse activityRIBOZYME PHARM INC·Filed 1999·Granted Mar 4, 2003·283 cites·3 claims
- 0485US9216204B2Bone targeted therapeutics and methods of making and using the sameMBC PHARMA INC·Filed 2013·Granted Dec 22, 2015·6 cites·8 claims
- 0585US8586781B2Bone targeted therapeutics and methods of making and using the sameKARPEISKY ALEXANDER·Filed 2009·Granted Nov 19, 2013·7 cites·7 claims
- 0672US10046055B2Bone targeted therapeutics and methods of making and using the sameMBC PHARMA INC·Filed 2015·Granted Aug 14, 2018·1 cites·11 claims
- 0770US2006292691A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0870US2007004667A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0968US2006247429A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1068US2006287266A1RNA interference mediated ihibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1168US2006217336A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1266US6482932B1Nucleoside triphosphates and their incorporation into oligonucleotidesRIBOZYME PHARM INC·Filed 1999·Granted Nov 19, 2002·21 cites·20 claims
- 1365US2006281175A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1465US2006275903A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1565US2022323474A1Drug combination treatments using bone-targeting therapeutics for bone and bone-related diseaseMBC Pharma·Filed 2022·Application pending·0 cites
- 1663US9334300B2Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonatesKARPEISKY ALEXANDER·Filed 2012·Granted May 10, 2016·1 cites·10 claims
- 1763US2006217337A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1863US2006247428A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1963US2006217335A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2063US2006217334A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2159US2018339055A1Bone targeted therapeutics and methods of making and using the sameMBC PHARMA INC·Filed 2018·Application pending·0 cites
- 2256US2005209180A1RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2355US11324767B2Drug combination treatments using bone-targeting therapeutics for bone and bone-related diseaseMBC PHARMA INC·Filed 2018·Granted May 10, 2022·0 cites·12 claims
- 2455US2005233329A1Inhibition of gene expression using duplex forming oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 2553US2005233998A1RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2652US2015105445A1RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)SIRNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2751US2014315851A1Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonatesMBC PHARMA INC·Filed 2014·Application pending·0 cites
- 2850US2003130186A1Conjugates and compositions for cellular deliveryFiled 2002·Application pending·0 cites
- 2950US2005020525A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3050US2007032441A1Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3148US2022213151A1Compositions and methods for treatment of distentable tissuesAURORA ONCOLOGY·Filed 2020·Application pending·0 cites
- 3248US2004009510A1Allosteric nucleic acid sensor moleculesFiled 2003·Application pending·0 cites
- 3346US2003144489A1Method for screening nucleic acid catalystsFiled 2002·Application pending·0 cites
- 3445US2003065155A1Nucleic acid sensor moleculesFiled 2002·Application pending·0 cites
- 3544US2003008295A1Nucleic acid sensor moleculesFiled 2001·Application pending·0 cites
- 3643US11298366B2Ibandronate conjugates of nucleoside antimetabolitesMBC PHARMA INC·Filed 2018·Granted Apr 12, 2022·0 cites·18 claims
- 3743US2002102568A1Nucleic acid sensor moleculesFiled 2001·Application pending·0 cites
- 3843US2003105308A1Nucleoside triphosphates and their incorporation into oligonucleotidesFiled 2001·Application pending·0 cites
- 3943US2016250247A1Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonatesMBC PHARMA INC·Filed 2016·Application pending·0 cites
- 4043US2008039414A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 4143US2003004122A1Nucleotide triphosphates and their incorporation into oligonucleotidesFiled 2001·Application pending·0 cites
- 4242US11219603B2Stable dosage form of etidronate-cytarabine conjugate, and use thereofMAXWELL BIOTECH GROUP LTD·Filed 2016·Granted Jan 11, 2022·0 cites·18 claims
- 4342US2011118335A1RNA Interference Mediated Inhibition Of Gene Expression Using Multifunctional Short Interfering Nucleic Acid (Multifunctional siNA)JADHAV VASANT·Filed 2010·Application pending·0 cites
- 4442US2005203044A1Small-mer compositions and methods of useSIRNA THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 4534US11045487B2Pharmaceutical preparation treating bone lesions caused by malignant neoplasmsMAXWELL BIOTECH GROUP LTD·Filed 2017·Granted Jun 29, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Shawn Zinnen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →